Male pattern baldness can be associated with prostate cancer. The prevalence of it is common among males in the United States. It is found that factors including heritability and androgens are associated to having a cause in both. It is known to affect about 50 percent of the male population. The proven link between the two continues to be a subject of research up to now.
Studies done to discover the relation between prostate cancer and male pattern baldness have shown that men who have baldness earlier in their life have a prevalence of developing it later on. Male pattern baldness is hereditary; androgen is implicated in the development. This condition precedes prostate cancer in most cases. The exact mechanisms resulting in the prevalence of the two continues to be unknown. What is understood that these two conditions have a typical biological and epidemiological risk factors which include aging, androgenic metabolism and hereditary.
The mentioned epidemiological and biological factors have led to a common hypothesis that prostate cancer and male pattern baldness are related. Nowadays, it's used to predict the occurrence of the risk of this cancer in males. Studies have found that males losing their hair possess a 50% excess risk of getting this cancer. Again, this association is explained using aging, androgen metabolism, and hereditary factors. It is presumed that these factors play an important role in occurrence of the two.
Male pattern baldness (MPB) can be used as a biological indicator of aging thus MPB can be used to predict pathological processes related to aging including atherogenesis and carcinogenesis. Androgen is seen as a necessary factor that contributes significantly. A hormone called dihydrotestosterone or DHT promotes both the proliferation of prostate cells and hair loss, and that men who were diagnosed were more likely to have bald heads. Various studies indicate that males with baldness have an increased risk.
The screening populations and health education programs has led to identify people with higher risk of developing problems. According to studies done on the relation, bald males at the age of 20 are at a high risk of developing prostate cancer later on in their life. The significance of using the link helps to identify susceptible groups of males at risk. These groups of people are monitored so that in the future, in case they have prostate cancer, it is detected early and treated. Since early baldness is a risk factor, then it makes sense to advice men with early hair loss to undergo more regular screening for any signs.
Richard R. Lotenfoe, MD, is a Fellow of the American College of Surgeons and Board Certified Urological Surgeon in Orlando, Florida. He specializes in the treatment of prostate cancer using the HIFU procedure.The HIFU Treatment uses ultrasound to destroy prostate cancer cells.
Celebration, FL 34747
Toll Free: (877) 458-8443
Local: (407) 584-7771
